Seeking Alpha

AC Immune Showcasing Precision Medicine Programs at AAIC 2023

Lausanne, Switzerland, July 3, 2023 – AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced upcoming presentations at ...
Seeking Alpha

AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43

The Michael J. Fox Foundation grant supports the development of AC Immune’s first-in-class TDP-43 PET tracer program Target ALS Foundation grant supports collaboration between AC Immune and ...